生物活性 | |||
---|---|---|---|
靶点 |
|
||
描述 | Administration of azaperone at weaning had a profound effect on preovulatory LH secretion as well as growth kinetics and estrogenicity of ovarian antral follicles[3]. Thiafentanil and azaperone, with or without etorphine, delivered rapid safe, effective, reversible field anaesthesia in healthy swamp buffalo[4]. Using azaperone alone the duration of immobility was 1.9 to 10.8 hours for mice and 0.9 to 2.4 hours for rats. The withdrawal reflex was not eliminated from mice receiving azaperone alone; however, the withdrawal reflex was eliminated from 0.9 to 2.4 hours in rats receiving azaperone. Azaperone produced a tachypnea in rats and male mice while a depressed respiratory rate was observed in female mice. Overall, azaperone alone was shown to provide sedation in mice as compared to a dose dependent anesthesia in rats. Azaperone and the azaperone-ketamine combination appear to be a suitable alternative to sedatives and anesthetics currently used in rats and mice[5]. |
临床研究 | |||||
---|---|---|---|---|---|
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
NCT01486615 | Anxiety | Phase 4 | Completed | - | Nepal ... 展开 >> B. P. Koirala Institute of Health Sciences Dharan, Koshi, Nepal, 56700 Dr Krishna Pokharel Dharan, Koshi, Nepal, 56700 收起 << |
NCT01486615 | - | Completed | - | - |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
3.05mL 0.61mL 0.31mL |
15.27mL 3.05mL 1.53mL |
30.54mL 6.11mL 3.05mL |
参考文献 |
---|